Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Toll-like receptor 4 (TLR4) is a key component of the innate immune response, recognizing pathogen-associated molecular patterns (PAMPs) such as lipopolysaccharides (LPS) from Gram-negative bacteria. Upon activation, TLR4 initiates signaling pathways that lead to the production of pro-inflammatory cytokines, playing a crucial role in fighting infections but also contributing to inflammation-related diseases. The TLR4 pathway involves the MyD88-dependent and TRIF-dependent signaling cascades, which activate transcription factors like NF-κB and IRFs, leading to the expression of genes involved in inflammation and immune response[1][2][3].
Activation of NF-κB and MAPK pathways leading to pro-inflammatory cytokine production
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Toll-like receptor 4 (TLR4) pathway (TLR4 pathway).